Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck & Co Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates


Wednesday, 13 Feb 2013 09:00am EST 

Merck & Co Inc announced that for first quarter of 2013, it expects non-GAAP EPS to be between $0.76 and $0.78, and the GAAP EPS range to be $0.37 to $0.42. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $0.85 for first quarter of 2013. 

Company Quote

59.17
0.32 +0.54%
22 Aug 2014